Company Overview:
lyell immunopharma inc - AOMR
AOMR Key Data
| Open $8.62 | Day Range 8.50 - 8.62 |
| 52 Week Range 7.36 - 10.34 | Market Cap $214.51M |
| Shares Outstanding 24.91M | Public Float 18.69M |
| Beta 1.27 | Rev. Per Employee N/A |
| P/E Ratio 4.77 | EPS $1.85 |
| Yield 1,486.64% | Dividend $0.32 |
| EX-DIVIDEND DATE Feb 20, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 90.51K |
|
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | | Average Target Price | 11.45 |
| Number of Ratings | 5 | | Current Quarters Estimate | 0.326 |
| FY Report Date | 06 / 2026 | | Current Year's Estimate | 1.307 |
| Last Quarter’s Earnings | 0.30 | | Median PE on CY Estimate | N/A |
| Year Ago Earnings | 0.59 | | Next Fiscal Year Estimate | 1.385 |
| | | Median PE on Next FY Estimate | N/A |
Earnings Per Share
|
This Quarter
|
Next Quarter
|
This Fiscal
|
Next Fiscal
|
|---|
| # of Estimates | 5 | 5 | 5 | 5 |
| Mean Estimate | 0.33 | 0.33 | 1.31 | 1.39 |
| High Estimates | 0.34 | 0.35 | 1.35 | 1.40 |
| Low Estimate | 0.31 | 0.32 | 1.26 | 1.34 |
| Coefficient of Variance | 4.63 | 3.86 | 3.40 | 1.88 |
Analysts Recommendations
|
Current
|
1 Month Ago
|
3 Months Ago
|
|---|
| BUY |
3
|
3
|
4
|
| OVERWEIGHT |
0
|
0
|
0
|
| HOLD |
2
|
2
|
2
|
| UNDERWEIGHT |
0
|
0
|
0
|
| SELL |
0
|
0
|
0
|
| MEAN |
Overweight
|
Overweight
|
Overweight
|
An error occurred while fetching the data.